{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:16:24Z","timestamp":1787001384848,"version":"build-2736575974"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1999,5,1]],"date-time":"1999-05-01T00:00:00Z","timestamp":925516800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[1999,5,1]],"date-time":"1999-05-01T00:00:00Z","timestamp":925516800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[1999,5]]},"DOI":"10.1023\/a:1006184028515","type":"journal-article","created":{"date-parts":[[2002,12,21]],"date-time":"2002-12-21T19:53:09Z","timestamp":1040500389000},"page":"117-123","source":"Crossref","is-referenced-by-count":22,"title":["Successful co\u2010treatment with LHRH\u2010agonist for ovarian over\u2010stimulation and cystic formation in premenopausal tamoxifen exposure"],"prefix":"10.1007","volume":"55","author":[{"given":"Ilan","family":"Cohen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ron","family":"Tepper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arie","family":"Figer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dov","family":"Flex","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremiah","family":"Shapira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoram","family":"Beyth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"207177_CR1","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/0090-8258(92)90273-L","volume":"45","author":"DM Wolf","year":"1992","unstructured":"Wolf DM, Jordan VC: Gynecological complications associated with long-term adjuvant tamoxifen therapy for breast cancer. Gynecol Oncol 45: 118\u2013128, 1992","journal-title":"Gynecol Oncol"},{"key":"207177_CR2","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1677\/joe.0.0700421","volume":"70","author":"GC Groom","year":"1976","unstructured":"Groom GC, Griffiths K: Effect of the anti-estrogen tamoxifen on plasma levels of luteinizing hormone, follicle stimulating hormone, prolactin, estradiol and progesterone in normal premenopausal women. J Endocrinol 70: 421\u2013428, 1976","journal-title":"J Endocrinol"},{"key":"207177_CR3","first-page":"779","volume":"64","author":"A Manni","year":"1980","unstructured":"Manni A, Pearson OH: Antiestrogen-induced remissions in premenopausal women with stage IV breast cancer: effects on ovarian function. Cancer Treat Rep 64: 779\u2013785, 1980","journal-title":"Cancer Treat Rep"},{"key":"207177_CR4","first-page":"4454","volume":"45","author":"Ludwig Breast Cancer Study Group","year":"1985","unstructured":"Ludwig Breast Cancer Study Group: A randomized trial of adjuvant combination chemotherapy with or without prednisone in premenopausal breast cancer patients with metastases in one to three axillary lymph nodes. Cancer Res 45: 4454\u20134459, 1985","journal-title":"Cancer Res"},{"key":"207177_CR5","first-page":"3152","volume":"46","author":"CA Sawka","year":"1986","unstructured":"Sawka CA, Pritchard KI, Paterson DJA, Sutherland DJA, Thomson DB, Shalley WE, Myres RE, Mobbs BG, Malkin A, Meakin JW: Role and mechanism of action of tamoxifen in premenopausal women with metastatic breast cancer. Cancer Res 46: 3152\u20133156, 1986","journal-title":"Cancer Res"},{"key":"207177_CR6","first-page":"624","volume":"47","author":"VC Jordan","year":"1987","unstructured":"Jordan VC, Fritz NF, Tormey DC: Endocrine effects of adjuvant chemotherapy and long-term tamoxifen administration on node-positive patients with breast cancer. Cancer Res 47: 624\u2013630, 1987","journal-title":"Cancer Res"},{"key":"207177_CR7","first-page":"1026","volume":"48","author":"PM Ravdin","year":"1988","unstructured":"Ravdin PM, Fritz NF, Tormey DC, Jordan VC: Endocrine status of premenopausal node-positive breast cancer patients following adjuvant chemotherapy and long term tamoxifen. Cancer Res 48: 1026\u20131029, 1988","journal-title":"Cancer Res"},{"key":"207177_CR8","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1093\/oxfordjournals.humrep.a138723","volume":"9","author":"A Shulman","year":"1994","unstructured":"Shulman A, Cohen I, Altaras M, Mayron R, Ben-Nun I, Tepper R, Beyth Y: Ovarian cyst formation in two pre-menopausal patients treated with tamoxifen for breast cancer. Human Reprod 9: 1427\u20131429, 1994","journal-title":"Human Reprod"},{"key":"207177_CR9","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/bjc.1994.116","volume":"69","author":"I Cohen","year":"1994","unstructured":"Cohen I, Rosen DJD, Altaras MM, Beyth Y: Tamoxifen treatment in premenopausal breast cancer patients may be associated with ovarian overstimulation, cystic formation, and fibroid overgrowth. Br J Cancer 69: 620\u2013621, 1994","journal-title":"Br J Cancer"},{"key":"207177_CR10","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/S0039-6109(16)45232-1","volume":"70","author":"DFC Gibson","year":"1990","unstructured":"Gibson DFC, Jordan VC: Adjuvant antiestrogenic therapy for breast cancer. Past, present, future. Surg Clin North Am 70: 1103\u20131113, 1990","journal-title":"Surg Clin North Am"},{"key":"207177_CR11","first-page":"4177","volume":"50","author":"U Lerner","year":"1990","unstructured":"Lerner U, Jordan VC: Development of antiestrogens and their use in breast cancer. Eighth Cain Memorial Award Lecture. Cancer Res 50: 4177\u20134189, 1990","journal-title":"Cancer Res"},{"key":"207177_CR12","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1093\/jnci\/87.18.1359","volume":"87","author":"LS Cook","year":"1995","unstructured":"Cook LS, Weiss NS, Schwartz SM, White E, McKnight B, Moore DE, Daling JR: Population based study of tamoxifen therapy and subsequent ovarian, endometrial and breast cancer. J Natl Cancer Inst 87: 1359\u20131364, 1995","journal-title":"J Natl Cancer Inst"},{"key":"207177_CR13","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3109\/02841869209088911","volume":"31","author":"M Baum","year":"1992","unstructured":"Baum M, Houghton J, Riley D: Results of the Cancer Research Campaign adjuvant trial for preoperative cyclophosphamide and long-term tamoxifen in early breast cancer, reported at the tenth year follow up. Acta Oncol 31: 251\u2013257, 1992","journal-title":"Acta Oncol"},{"key":"207177_CR14","first-page":"54","volume":"6","author":"B Healey","year":"1987","unstructured":"Healey B, Tormey DC, Gray S, Taylor S, Cummings E: Arterial and venous thrombosis events in ECOG adjuvant breast cancer trials. Proc Am Oncol 6: 54\u201357, 1987","journal-title":"Proc Am Oncol"},{"key":"207177_CR15","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/bjc.1986.106","volume":"53","author":"MR Williams","year":"1986","unstructured":"Williams MR, Walker KJ, Turkes A, Blamey RW, Nicholson RI: The use of LHRH agonist (ICI 118360, Zoladex) in advanced premenopausal breast cancer. Br J Cancer 53: 629\u2013636, 1986","journal-title":"Br J Cancer"},{"key":"207177_CR16","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1210\/edrv-11-2-221","volume":"11","author":"RI Santen","year":"1990","unstructured":"Santen RI, Manni A, Harvey H, Redmond C: Endocrine treatment of breast cancer in women. Endocrin Rev 11: 221\u2013265, 1990","journal-title":"Endocrin Rev"},{"issue":"Suppl","key":"207177_CR17","first-page":"94","volume":"4","author":"JFR Robertson","year":"1990","unstructured":"Robertson JFR, Nicholson RI, Blamey RW: The LHRH agonist Zoladex and antiestrogen tamoxifen: a rational combination in premenopausal women with breast cancer. Gynecol Endocrinol (Suppl) 4: 94, 1990","journal-title":"Gynecol Endocrinol"},{"key":"207177_CR18","first-page":"76","volume":"124","author":"JGM Klijn","year":"1992","unstructured":"Klijn JGM: LHRH agonist in the treatment of metastatic breast cancer. Ten years' experience. Recent Results Cancer Res 124: 76\u201390, 1992","journal-title":"Recent Results Cancer Res"},{"key":"207177_CR19","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/978-88-470-2186-0_9","volume":"124","author":"K Hoffken","year":"1992","unstructured":"Hoffken K: LHRH agonist in the treatment of premenopausal patients with advanced breast cancer. Recent Results Cancer Res 124: 91\u2013104, 1992","journal-title":"Recent Results Cancer Res"},{"key":"207177_CR20","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1177\/030089169107700211","volume":"77","author":"C Brambilla","year":"1991","unstructured":"Brambilla C, Escobedo A, Artioli R, Lechuga MJ, Motta M, Bonadonna G: Medical castration with Zoladex: a conservative approach to premenopausal breast cancer. Tumori 77: 145\u2013150, 1991","journal-title":"Tumori"},{"key":"207177_CR21","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1210\/jcem-42-3-432","volume":"42","author":"JR Young","year":"1976","unstructured":"Young JR, Jaffe RB: Strength and duration characteristics of estrogen effects on gonadotropin response to gonadotropinreleasing hormone in women: II. Effects of varying concentration of estradiol. J Clin Endocrin Metab 42: 432\u2013437, 1976","journal-title":"J Clin Endocrin Metab"},{"key":"207177_CR22","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1093\/jnci\/86.7.527","volume":"86","author":"B Fisher","year":"1994","unstructured":"Fisher B, Costantino JP, Redmond CK, Fisher ER, Wickerham L, Cronin WM: Endometrial cancer in tamoxifen-treated breast cancer patients: Findings from the National Surgical Adjuvant Breast and Bowel project (NSABP) B-14. J Natl Cancer Inst 86: 527\u2013537, 1994","journal-title":"J Natl Cancer Inst"},{"key":"207177_CR23","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1093\/jnci\/83.20.1488","volume":"83","author":"VC Jordan","year":"1991","unstructured":"Jordan VC, Fritz NF, Langan\u2013Fahey S, Thompson M, Tormey DC: Alteration of endocrine parameters in premenopausal women with breast cancer during long term adjuvant tamoxifen therapy. J Natl Cancer Inst 83: 1488\u20131491, 1991","journal-title":"J Natl Cancer Inst"},{"key":"207177_CR24","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1200\/JCO.1991.9.7.1283","volume":"9","author":"MC Sunderland","year":"1991","unstructured":"Sunderland MC, Osborne CK: Tamoxifen in premenopausal patients with metastatic breast cancer: A review. J Clin Oncol 9: 1283\u20131297, 1991","journal-title":"J Clin Oncol"},{"key":"207177_CR25","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/BF01806790","volume":"7","author":"ME Lippman","year":"1986","unstructured":"Lippman ME, Dickson RB, Bates S: Autocrine and paracrine growth regulation of human breast cancer. Breast Cancer Res Treat 7: 59\u201370, 1986","journal-title":"Breast Cancer Res Treat"},{"key":"207177_CR26","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1038\/bjc.1991.457","volume":"64","author":"Y Iino","year":"1991","unstructured":"Iino Y, Wolf DM, Langan\u2013Fahey SM, Johnson DA, Ricchio M, Thompson ME, Jordan VC: Reversible control of estradiolstimulated growth of MCF-7 tumors by tamoxifen in the athymic mouse. Br J Cancer 64: 1019\u20131024, 1991","journal-title":"Br J Cancer"},{"key":"207177_CR27","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0163-7258(84)90043-3","volume":"25","author":"BJA Furr","year":"1984","unstructured":"Furr BJA, Jordan VC: The pharmacology and clinical uses of tamoxifen. Pharmacol Ther 25: 127\u2013205, 1984","journal-title":"Pharmacol Ther"},{"key":"207177_CR28","first-page":"2790","volume":"44","author":"PD Darbre","year":"1984","unstructured":"Darbre PD, Curtis S, King RJ: Effects of estradiol and tamoxifen on human breast cancer cells in serum-free culture. Cancer Res 44: 2790\u20132793, 1984","journal-title":"Cancer Res"},{"key":"207177_CR29","first-page":"299","volume":"35","author":"CJ Jolles","year":"1990","unstructured":"Jolles CJ, Smotkin D, Ford KL, Jones KP: Cystic ovarian necrosis complicating tamoxifen therapy for breast cancer in a premenopausal woman. J Reprod Med 35: 299\u2013300, 1990","journal-title":"J Reprod Med"},{"key":"207177_CR30","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0015-0282(16)55688-X","volume":"59","author":"RI Barbieri","year":"1993","unstructured":"Barbieri RI, Ferraci AL, Droesch JM, Rachelson BL: Ovarian torsion in a premenopausal woman treated with tamoxifen for breast cancer. Fertil Steril 59: 459\u2013460, 1993","journal-title":"Fertil Steril"},{"key":"207177_CR31","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/0002-9378(95)91511-7","volume":"172","author":"D Hochner-Celnikier","year":"1995","unstructured":"Hochner-Celnikier D, Anteby E, Yagel S: Ovarian cysts in tamoxifen treated premenopausal women with breast cancer. A management dilemma. Am J Obstet Gynecol 172: 1323\u20131324, 1995","journal-title":"Am J Obstet Gynecol"},{"key":"207177_CR32","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0002-9378(96)70386-1","volume":"174","author":"A Shushan","year":"1996","unstructured":"Shushan A, Peretz T, Uziely B, Lewin A, Mor-Yosef S: Ovarian cysts in premenopausal and postmenopausal tamoxifen-treated women with breast cancer. Am J Obstet Gynecol 174: 141\u2013144, 1996","journal-title":"Am J Obstet Gynecol"},{"key":"207177_CR33","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1016\/0140-6736(91)93096-R","volume":"337","author":"DV Spicer","year":"1991","unstructured":"Spicer DV, Pike MC, Henderson BE: Ovarian cancer and long tamoxifen treatment in premenopausal women. Lancet 337: 1414\u20131417, 1991","journal-title":"Lancet"},{"key":"207177_CR34","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0002-9378(92)91854-4","volume":"166","author":"PV Dilts","year":"1992","unstructured":"Dilts PV, Hopkins MP, Chang AE, Cody RL: Rapid growth of leiomyoma in patient receiving tamoxifen. Am J Obstet Gynecol 166: 167\u2013168, 1992","journal-title":"Am J Obstet Gynecol"},{"key":"207177_CR35","first-page":"3","volume-title":"Advances in Gynecology and Obstetrics: General Gynecology","author":"AV Schally","year":"1990","unstructured":"Schally AV: The use of LHRH analog in gynecology and tumor therapy. In: Belfast P, Pimotti JA, Eskes TKAB (eds) Advances in Gynecology and Obstetrics: General Gynecology. Vol 6. Parthenon Publishing. Carnforth, 1990, pp. 3\u201320"},{"key":"207177_CR36","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/0002-9378(90)90439-E","volume":"162","author":"JB Jacobson","year":"1990","unstructured":"Jacobson JB: Effects of nafarelin on bone density. Am J Obstet Gynecol 162: 591\u2013592, 1990","journal-title":"Am J Obstet Gynecol"},{"key":"207177_CR37","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/S0015-0282(16)55820-8","volume":"59","author":"AR Scialli","year":"1993","unstructured":"Scialli AR, Jestica RI, Simon JA: Leuprolide acetate and bone mineral density measured by quantitative digitized radiography. Fertil Steril 59: 674\u2013676, 1993","journal-title":"Fertil Steril"},{"key":"207177_CR38","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1016\/S0002-9378(96)70594-X","volume":"174","author":"PJ DiSaia","year":"1996","unstructured":"DiSaia PJ, Grosen EA, Kurosaki T, Gildea M, Cowan B, Anton-Culver H: Hormone replacement therapy in breast cancer survivors: a cohort study. Am J Obstet Gynecol 174: 1494\u20131498, 1996","journal-title":"Am J Obstet Gynecol"},{"key":"207177_CR39","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/S0140-6736(97)11423-4","volume":"351","author":"Early Breast Cancer Trialists' Collaborative Group","year":"1998","unstructured":"Early Breast Cancer Trialists' Collaborative Group: Tamoxifen for early breast cancer: an overview of the randomized trials. Lancet 351: 1451\u20131467, 1998","journal-title":"Lancet"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1006184028515.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1006184028515\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1023\/A:1006184028515","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1006184028515.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T00:17:57Z","timestamp":1750465077000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1006184028515"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,5]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1999,5]]}},"alternative-id":["207177"],"URL":"https:\/\/doi.org\/10.1023\/a:1006184028515","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,5]]}}}